![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Rheumatoid Arthritis |
Free Subscription
1 Ann Rheum Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Rheumatoid Arthritis is free of charge.
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in
patients with rheumatoid arthritis or psoriatic arthritis: a national real-world
cohort study.
Ann Rheum Dis. 2023 Mar 3:ard-2022-223636. doi: 10.1136/ard-2022-223636.
PubMed
Abstract available
The association between systemic immune-inflammation index and rheumatoid
arthritis: evidence from NHANES 1999-2018.
Arthritis Res Ther. 2023;25:34.
PubMed
Abstract available
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between
four ethnically diverse populations.
Arthritis Res Ther. 2023;25:37.
PubMed
Abstract available
A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib)
ameliorates lupus nephritis and serum-induced arthritis in murine models.
Clin Exp Immunol. 2023;211:31-45.
PubMed
Abstract available
Use of Disease-modifying Antirheumatic Drugs, Biologics, and Corticosteroids in
Older Patients With Rheumatoid Arthritis Over 20 Years.
J Rheumatol. 2021;48:977-984.
PubMed
Abstract available
Long-term Glucocorticoid Use in Rheumatoid Arthritis.
J Rheumatol. 2021;48:1342.
PubMed
Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes
in Patients With Rheumatoid Arthritis.
J Rheumatol. 2021;48:1221-1229.
PubMed
Abstract available
Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid
Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use.
J Rheumatol. 2021;48:1504-1507.
PubMed
Abstract available
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor
Inhibitor As First Biologic in Rheumatoid Arthritis.
J Rheumatol. 2021;48:1512-1518.
PubMed
Abstract available
Meaningful Change Thresholds for Patient-Reported Outcomes Measurement
Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With
Rheumatoid Arthritis.
J Rheumatol. 2021;48:1239-1242.
PubMed
Abstract available
Axial Articular Manifestations in Primary Sjogren Syndrome: Have We Been Missing
Spondyloarthritis for All This Time?
J Rheumatol. 2021;48:963-964.
PubMed
Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness
in Primary Sjogren Syndrome.
J Rheumatol. 2021;48:1290-1294.
PubMed
Abstract available
Lymphoma and Sjogren Syndrome: A Common Overlapping Syndrome?
J Rheumatol. 2021;48:1343.
PubMed
Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients
in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
PLoS One. 2023;18:e0282564.
PubMed
Abstract available
Identification of Sjogren's syndrome patient subgroups by clustering of labial
salivary gland DNA methylation profiles.
PLoS One. 2023;18:e0281891.
PubMed
Abstract available
[Assessment of interactions and dosage recommendations of synthetic
DMARDs-Evidence-based and consensus-based recommendations based on a systematic
literature search].
Z Rheumatol. 2023;82:151-162.
PubMed
Abstract available
[Adult-onset Still's disease : Diagnosis and treatment according to the new S2e
guidelines of the German Society of Rheumatology (DGRh)].
Z Rheumatol. 2023;82:134-142.
PubMed
Abstract available
[DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still's disease
(AOSD)].
Z Rheumatol. 2022;81.
PubMed
[Guideline report on the DGRh S2e guidelines on diagnostics and treatment of
adult-onset Still's disease (AOSD)].
Z Rheumatol. 2022;81.
PubMed
[National consensus statement by the Austrian Societies for Rheumatology,
Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the
management of latent tuberculosis and the associated utilization of biologic and
targeted synthetic DMA
Z Rheumatol. 2023;82:163-174.
PubMed
Abstract available
[How many patients with inflammatory rheumatic diseases have the technical
prerequisites for video consultations and are also willing to use this to carry
out visits by medical specialist visits?].
Z Rheumatol. 2023;82:102-107.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by